Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications metabolically healthy obesity risk incident ischemic heart disease stroke ���
… Sapna Rao Pharmacoepidemiology and Risk Management Headquarters - Research Triangle Park, North … a Research Epidemiologist in the Pharmacoepidemiology and Risk Management group with RTI-HS. She has 10 years of … advance causal methods in patients with chronic kidney disease. While working on her doctorate degree, she also …
… Veena Hoffman Pharmacoepidemiology and Risk Management Telecommuter - USA MPH, Epidemiology BS, … in the development and validation of claims-based disease and outcome algorithms. Ms. Hoffman has extensive …
… the SMDM 45th Annual North American Meeting. Can monetary risk preference explain health behavior and health …
Webinar: Beyond Controlling for Confounding Share on: Thursday, September 27, 2018, 10 - 11am Watch the Recording Going One Step Further in Observational Studies: Design Strategies Randomized clinical trials (RCTs) are the gold standard to quantify the …
… attributes that enable a more active lifestyle with lower risk of inhibitor development. Cano V, Mansfield C, Pierce A, …
… product. We provide: HEOR and market access strategies Disease area and portfolio strategies 2) Analysis: Understand …
… post-market pregnancy requirements and safety in rare disease and gene therapy. Here are the details. #314: … pregnancy studies. #362: Assessing Safety in Rare Disease and Gene Therapy Wednesday, June 28 • 4:00pm - 5:00pm … historical control or synthetic control) to assess rare disease treatment safety advantages and example for setting …
… from social media posts on the impact of alzheimer's disease on care partners. Frederiksen KS, Crawford R, … Matters Most™" to individuals living with Alzheimer's disease and care partners: a conceptual model of Alzheimer's disease. Romano CD, Slota C, Bratlee-Whitaker E, Edwards T, …
… will be presented at National Kidney Foundation SCM23. Disease burden and disease progression of young adult patients with autosomal dominant polycystic kidney disease. Davenport E, Zhou X, Wang J, Nunna S, Oberdhan D, …
Lola Xiao Health Economics Telecommuter - USA MSc, Health Finance and Management Johns Hopkins Bloomberg School of Public Health, Baltimore, DE BS, Business and Finance New York University, Shanghai, China Lola (Ziyi) Xiao, MHS, is a Health Outcomes …